{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:13:11Z","timestamp":1786993991424,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mathematical Biosciences"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.mbs.2017.01.005","type":"journal-article","created":{"date-parts":[[2017,1,14]],"date-time":"2017-01-14T11:00:58Z","timestamp":1484391658000},"page":"92-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Pre-exposure prophylaxis and antiretroviral treatment interventions with drug resistance"],"prefix":"10.1016","volume":"285","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5610-1076","authenticated-orcid":false,"given":"Komi","family":"Afassinou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faraimunashe","family":"Chirove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8926-0009","authenticated-orcid":false,"given":"Keshlan S.","family":"Govinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mbs.2017.01.005_bib0001","unstructured":"UNAIDS, World AIDS day, 2015, Accessed on 25\/05\/2016, available on: http:\/\/www.unaids.org\/en\/resources\/fact-sheet."},{"key":"10.1016\/j.mbs.2017.01.005_bib0002","unstructured":"Global health observatory data, number of death due to HIV\/AIDS, accessed on 25\/05\/2016, Available on: www.who.int\/gho\/hiv\/epidemicstatus\/deathstext\/en\/."},{"key":"10.1016\/j.mbs.2017.01.005_bib0003","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment","volume":"331","author":"Connor","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mbs.2017.01.005_sbref0002","article-title":"Preexposure prophylaxis for HIV infection: where have we been and where are we going?","volume":"63","author":"Baeten","year":"2013","journal-title":"J. Acqui. Immune Deficiency Syndr. (1999)"},{"key":"10.1016\/j.mbs.2017.01.005_bib0005","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/cid\/cit085","article-title":"A pill for HIV prevention: deja vu all over again?","volume":"56","author":"Myers","year":"2013","journal-title":"Clinic. Infectious Diseases"},{"key":"10.1016\/j.mbs.2017.01.005_bib0006","series-title":"Presented at: 6th IAS Conference on HIV Pathogenesis Treatment and Prevention, Rome, Italy, 17\u201320","article-title":"Antiretroviral pre-exposure prophylaxis for HIV prevention among heterosexual african men and women: the partners prep study","author":"Baeten","year":"2011"},{"key":"10.1016\/j.mbs.2017.01.005_bib0007","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1086\/507306","article-title":"Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges","volume":"194","author":"Subbarao","year":"2006","journal-title":"J. Infectious Diseases"},{"key":"10.1016\/j.mbs.2017.01.005_sbref0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050028","article-title":"Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir","volume":"5","author":"Garcia-Lerma","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.mbs.2017.01.005_bib0009","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Pre-exposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mbs.2017.01.005_sbref0008","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000391","article-title":"Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection","volume":"2","author":"Garcia-Lerma","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.mbs.2017.01.005_bib0011","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1128\/JVI.74.4.1767-1774.2000","article-title":"Prophylactic and therapeutic benefits of short-term 9-[2-(r)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA","volume":"74","author":"Rompay","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.mbs.2017.01.005_bib0012","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1097\/00002030-200309050-00005","article-title":"Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection","volume":"17","author":"Fiebig","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.mbs.2017.01.005_bib0013","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1128\/JCM.02196-07","article-title":"Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the united states","volume":"46","author":"Owen","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.mbs.2017.01.005_bib0014","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jtbi.2013.12.021","article-title":"Impact of tenofovir gel as a prEP on HIV infection: a mathematical model","volume":"347","author":"Rahman","year":"2014","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.mbs.2017.01.005_bib0015","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/srep00185","article-title":"Modelling dynamic interventions between pre-exposure prophylaxis interactions and treatment programs: prediction HIV transmission and resistance","volume":"1","author":"Supervie","year":"2011","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mbs.2017.01.005_bib0016","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1371\/journal.pone.0002077","article-title":"The impact of pre-exposure prophylaxis (prEP) on HIV epidemics in africa and india: a simulation study","volume":"3","author":"Vissers","year":"2008","journal-title":"J. PLoS ONE"},{"key":"10.1016\/j.mbs.2017.01.005_bib0017","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nm.2649","article-title":"A quantitative basis for antiretroviral therapy for HIV-1 infection","volume":"18","author":"Jilek","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.mbs.2017.01.005_bib0018","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1086\/422601","article-title":"Decrease HIV transmission after a policy of providing free access to highly active antiretroviral therapy in taiwan","volume":"190","author":"Fang","year":"2004","journal-title":"J. Infectious Diseases"},{"key":"10.1016\/j.mbs.2017.01.005_bib0019","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/17486700903325167","article-title":"Modelling the effect of condom use and antiretroviral therapy in controlling HIV\/AIDS among heterosexuals, homosexuals and bisexuals","volume":"11","author":"Malunguza","year":"2010","journal-title":"Comput. Math. Methods Med."},{"key":"10.1016\/j.mbs.2017.01.005_bib0020","unstructured":"D. Smith, P. Kebaabetswe, K. Disasi, D. Fleming, L. Paxton, M. Davis, Antiretroviral resistance in not an important risk of the oral tenofovir prophylaxis trial in botswana: a simple mathematical modelling approach, 2006, XIV International AIDS Conference, Toronto, Canada 13\u201318 August."},{"key":"10.1016\/j.mbs.2017.01.005_bib0021","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.hivar.2012.04.001","article-title":"Assessing the impact of using antiretroviral drugs as pre-exposure vaccines","volume":"11","author":"Bhunu","year":"2012","journal-title":"J. HIV AIDS Rev."},{"key":"10.1016\/j.mbs.2017.01.005_bib0022","series-title":"Population Biology of Infectious Diseases","author":"Anderson","year":"1982"},{"key":"10.1016\/j.mbs.2017.01.005_bib0023","first-page":"599","article-title":"Mathematics of infectious diseases","volume":"42","author":"Hethcote","year":"2000","journal-title":"Soc. Ind. Appl. Math."},{"key":"10.1016\/j.mbs.2017.01.005_bib0024","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0025-5564(02)00108-6","article-title":"Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission","volume":"180","author":"Driessche","year":"2002","journal-title":"J. Math. Biosci."},{"key":"10.1016\/j.mbs.2017.01.005_bib0025","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00178324","article-title":"On the definition and the computation of the basis reproduction ratio R0 in models for infectious diseases in heterogeneous populations","volume":"28","author":"Diekmann","year":"1990","journal-title":"J. Math. Biol."},{"key":"10.1016\/j.mbs.2017.01.005_bib0026","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1137\/120876642","article-title":"Global stability of the infectious disease models using lyapunov fucntions","volume":"73","author":"Shuai","year":"2013","journal-title":"SIAM J. Appl. Math."},{"key":"10.1016\/j.mbs.2017.01.005_bib0027","series-title":"Regional Conference in Applied Mathematics","article-title":"The stability of dynamical systems","author":"LaSalle","year":"1976"},{"key":"10.1016\/j.mbs.2017.01.005_bib0028","unstructured":"Botswana AIDS impact survey BAIS IV 2013, summary results, Avalaible on: wwww.cso.go.bw\/images\/aidssummary.pdf. Accessed on 30\/May\/2016."},{"key":"10.1016\/j.mbs.2017.01.005_bib0029","unstructured":"Progress report of the national response to the 2011 declaration of comments on HIV and AIDS, Available on: www.unaids.org\/sites\/default\/files\/country\/documents\/BWA-narrative-report-2015.pdf. Accessed on 15\/June\/2016."},{"key":"10.1016\/j.mbs.2017.01.005_bib0030","unstructured":"Botswana HIV\/AIDS, Available on: www.worldlifeexpectancy.com\/botswana-life-expectancy. Accessed 30\/May\/2016."},{"key":"10.1016\/j.mbs.2017.01.005_bib0031","first-page":"1211","article-title":"Risk of drug resistance among persons acquiring HIV within a randomized clinical trial of single- or dual-agent pre-exposure prophylaxis","volume":"211","author":"Lehman","year":"2015","journal-title":"J. Infectious Diseases"},{"key":"10.1016\/j.mbs.2017.01.005_bib0032","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for prevention of HIV infection in women","volume":"329","author":"Karim","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.mbs.2017.01.005_bib0033","unstructured":"Statistics south africa, mid-year population estimates, statistical release p0302, 2013, 1\u201319, http:\/\/beta2.statssa.gov.za\/publications\/P0302\/P03022013.pdf. Accessed on 15\/July\/2016."}],"container-title":["Mathematical Biosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025556417300226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025556417300226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T19:02:09Z","timestamp":1572721329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025556417300226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":33,"alternative-id":["S0025556417300226"],"URL":"https:\/\/doi.org\/10.1016\/j.mbs.2017.01.005","relation":{},"ISSN":["0025-5564"],"issn-type":[{"value":"0025-5564","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-exposure prophylaxis and antiretroviral treatment interventions with drug resistance","name":"articletitle","label":"Article Title"},{"value":"Mathematical Biosciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mbs.2017.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}